Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 30,984 | 24,037 | 23,308 | 23,771 | 30,972 |
| Cost of Goods | 13,276 | 10,542 | 9,452 | 10,789 | 13,738 |
| Gross Profit | 17,708 | 13,495 | 13,856 | 12,982 | 17,234 |
| Operating Expenses | 15,228 | 13,855 | 13,752 | 17,044 | 16,338 |
| Operating Income | 2,756 | 182 | 556 | -3,273 | 1,634 |
| Interest Expense | 1,094 | 1,205 | 1,233 | 1,299 | 1,281 |
| Other Income | -2,210 | -392 | -191 | 111 | -255 |
| Pre-tax Income | -548 | -1,415 | -868 | -4,461 | 98 |
| Income Tax | 67 | -317 | 713 | 55 | -452 |
| Net Income Continuous | -615 | -1,098 | -1,581 | -4,516 | 550 |
| Net Income | $-615 | $-1,098 | $-1,581 | $-4,516 | $550 |
| EPS Basic Total Ops | -0.10 | -0.30 | -0.40 | -1.20 | 0.20 |
| EPS Basic Continuous Ops | -0.15 | -0.28 | -0.41 | -1.18 | 0.14 |
| EPS Diluted Total Ops | -0.10 | -0.30 | -0.40 | -1.20 | 0.20 |
| EPS Diluted Continuous Ops | -0.15 | -0.28 | -0.41 | -1.18 | 0.14 |
| EBITDA(a) | $5,562 | $2,128 | $2,607 | $-1,264 | $3,679 |